VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) was the recipient of a significant drop in short interest in August. As of August 15th, there was short interest totalling 1,670,000 shares, a drop of 17.3% from the July 31st total of 2,020,000 shares. Based on an average daily volume of 142,100 shares, the short-interest ratio is currently 11.8 days.
Hedge Funds Weigh In On VanEck Pharmaceutical ETF
A number of large investors have recently modified their holdings of the company. Avestar Capital LLC bought a new stake in VanEck Pharmaceutical ETF during the 4th quarter valued at $4,284,000. Independent Advisor Alliance increased its stake in shares of VanEck Pharmaceutical ETF by 100.8% in the 4th quarter. Independent Advisor Alliance now owns 98,473 shares of the company’s stock worth $7,939,000 after acquiring an additional 49,423 shares in the last quarter. Assetmark Inc. increased its stake in shares of VanEck Pharmaceutical ETF by 107.5% in the 4th quarter. Assetmark Inc. now owns 5,485 shares of the company’s stock worth $446,000 after acquiring an additional 2,841 shares in the last quarter. WT Wealth Management increased its stake in shares of VanEck Pharmaceutical ETF by 11.7% in the 4th quarter. WT Wealth Management now owns 39,613 shares of the company’s stock worth $3,223,000 after acquiring an additional 4,155 shares in the last quarter. Finally, Comerica Bank grew its position in VanEck Pharmaceutical ETF by 39.4% during the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock valued at $121,000 after purchasing an additional 378 shares during the last quarter.
VanEck Pharmaceutical ETF Trading Up 0.7 %
PPH stock opened at $99.43 on Friday. The firm has a 50 day moving average of $93.88 and a 200-day moving average of $90.90. VanEck Pharmaceutical ETF has a 12 month low of $74.05 and a 12 month high of $99.44. The firm has a market capitalization of $670.16 million, a P/E ratio of 21.04 and a beta of 0.72.
VanEck Pharmaceutical ETF Cuts Dividend
VanEck Pharmaceutical ETF Company Profile
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Featured Stories
- Five stocks we like better than VanEck Pharmaceutical ETF
- ETF Screener: Uses and Step-by-Step Guide
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- What is the Hang Seng index?
- Why Dell Can Continue Winning in AI and Beyond
- How to Invest in the FAANG Stocks
- MarketBeat Week in Review – 8/26 – 8/30
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.